Neuropathic pain: delving into the oxidative origin and the possible implication of transient receptor potential channels by Carrasco Romero, Cristina et al.
REVIEW
published: 14 February 2018
doi: 10.3389/fphys.2018.00095
Frontiers in Physiology | www.frontiersin.org 1 February 2018 | Volume 9 | Article 95
Edited by:
Ali Mobasheri,
University of Surrey, United Kingdom
Reviewed by:
Felipe Simon,
Universidad Andrés Bello, Chile
Enrique Soto,






This article was submitted to
Membrane Physiology and Membrane
Biophysics,
a section of the journal
Frontiers in Physiology
Received: 25 October 2017
Accepted: 29 January 2018
Published: 14 February 2018
Citation:
Carrasco C, Nazirogˇlu M,
Rodríguez AB and Pariente JA (2018)
Neuropathic Pain: Delving into the
Oxidative Origin and the Possible




Neuropathic Pain: Delving into the
Oxidative Origin and the Possible
Implication of Transient Receptor
Potential Channels
Cristina Carrasco 1*, Mustafa Nazirogˇlu 2, Ana B. Rodríguez 1 and José A. Pariente 1
1 Department of Physiology, Faculty of Sciences, University of Extremadura, Badajoz, Spain, 2 Neuroscience Research Center,
Suleyman Demirel University, Isparta, Turkey
Currently, neuropathic pain is an underestimated socioeconomic health problem affecting
millions of people worldwide, which incidence may increase in the next years due to
chronification of several diseases, such as cancer and diabetes. Growing evidence
links neuropathic pain present in several disorders [i.e., spinal cord injury (SCI), cancer,
diabetes and alcoholism] to central sensitization, as a global result of mitochondrial
dysfunction induced by oxidative and nitrosative stress. Additionally, inflammatory signals
and the overload in intracellular calcium ion could be also implicated in this complex
network that has not yet been elucidated. Recently, calcium channels namely transient
receptor potential (TRP) superfamily, including members of the subfamilies A (TRAP1), M
(TRPM2 and 7), and V (TRPV1 and 4), have demonstrated to play a role in the nociception
mediated by sensory neurons. Therefore, as neuropathic pain could be a consequence of
the imbalance between reactive oxygen species and endogen antioxidants, antioxidant
supplementationmay be a treatment option. This kind of therapy would exert its beneficial
action through antioxidant and immunoregulatory functions, optimizing mitochondrial
function and even increasing the biogenesis of this vital organelle; on balance, antioxidant
supplementation would improve the patient’s quality of life. This review seeks to
deepen on current knowledge about neuropathic pain, summarizing clinical conditions
and probable causes, the relationship existing between oxidative stress, mitochondrial
dysfunction and TRP channels activation, and scientific evidence related to antioxidant
supplementation.
Keywords: neuropathic pain, oxidative stress, inflammation, mitochondrial dysfunction, TRP channels,
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INTRODUCTION
Currently, neuropathic pain (NP) is an underestimated socioeconomic health problem affecting
millions of people worldwide. It has been recently redefined by the International Association for
the Study of Pain as a “pain caused by lesion or disease of the somatosensory system” and it may
appear in a wide range of conditions; it can be classified into peripheral or central NP, depending
on anatomic location of the lesion or disease. Without a specific diagnostic tool, both clinicians
and researchers might use a grading system with different levels of certainty about the presence
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of NP (“possible,” “probable,” and “definite”) in a patient;
however, it should be mentioned that coexisting NP and other
types of pains (such as nociceptive pain) can make difficult a
reliable distinction (Treede et al., 2008; Jensen et al., 2011). The
common symptoms of different types of NP are mechanical
allodynia and hyperalgesia. Unlike nociceptive pain, commonly
prescribed analgesics often fail in alleviating NP. Thus, it can
become a chronic and hardly bearable condition, recently called
refractory NP. In some cases, this most severe NP may lead to
increased episodes of depression and suicide (Torrance et al.,
2013; Hassler et al., 2014; Kawaguchi et al., 2014).
Further research is needed to understand underlying
mechanisms of NP that allow to design individual and rational
treatment strategies. Growing evidence points thatmitochondrial
dysfunction induced by oxidative and nitrosative stress, along
with inflammation, constitute the physiopathological basis for
the development of several diseases (Carrasco et al., 2015).
Regarding to NP, this adverse context leads to peripheral and
central sensitization. It must be considered that mammalian
nerves are especially susceptible to free radicals, including
oxygen (ROS) and nitrogen reactive species (RNS), due to their
high content in phospholipids and axonal mitochondrion; in
addition, neuronal antioxidant defenses are weak (Areti et al.,
2014). Studies about antioxidant supplementation in animal
models of NP point that hydroxyl (•OH) and superoxide
(O•−2 ) radicals and nitric oxide (
•NO) might be involved in
the physiopathology of this kind of pain (Kawaguchi et al.,
2014). However, the way these messenger molecules regulate
pain signaling is still poorly understood. In addition, overload
intracellular calcium ion (Ca2+) has also an important role in
the etiology of NP. Ca2+ enters cells in different ways including
cation channels. Voltage gated calcium channels and chemical
channels (i.e., glutamate) are well known calcium channels
(Kumar et al., 2014). Moreover, new calcium channels namely
transient receptor potential (TRP) superfamily were discovered
in eye cells of Drosophila flyers (Hardie, 2011; Nazirogˇlu,
2011). In different species, TRP superfamily is divided into 30
channels within seven subfamilies such as TRPA (ankyrin),
TRPC (canonical), TRPM (melastatin), TRPML (mucolipin),
TRPP (polycystin), TRPV (vanilloid), and TPRN (NomPC),
nevertheless there are 28 subfamilies within 6 subgroups in
mammalian (Hardie, 2011; Nazirogˇlu, 2011; Uchida et al., 2017).
At least, nine members of TRP superfamily are activated by
oxidative stress including TRPM2, TRPM7, TRPA1, TRPC3,
TRPC5, TRPC6, TRPV1, TRPV3, and TRPV4 (Ogawa et al.,
2016). Dorsal root ganglion (DRG) neurons play an important
role in the painful NP. There is no barrier between the DRG
and blood and compounds with high molecular weight can
Abbreviations: APN, Alcoholic peripheral neuropathy; CIPN, chemotherapy-
induced peripheral neuropathy; DRG, dorsal root ganglion; ETC, mitochondrial
electron transport chain; GSH, glutathione; NAC, N acetyl cysteine; NP,
neuropathic pain; PARP-, poly (ADP-ribose) polymerase-1; PDN, peripheral
diabetic neuropathy; PKC, protein kinase C; ROS, reactive oxygen species;
RNS, reactive nitrogen species; SCI, spinal cord injury; TRP, transient receptor
potential; TRPA1, transient receptor potential ankyrin 1; TRPM2, transient
receptor potential melastatin 2; TRPV1, transient receptor potential vanilloid 1;
TRPV4, transient receptor potential vanilloid 4.
easily diffuse into the DRG (Abram et al., 2006). Expression
levels of TRPA1, TRPM2, TRPV1, and TRPV4 channels are
high in the DRG and trigeminal ganglia neurons (Kobayashi
et al., 2005; Obata et al., 2005; Fonfria et al., 2006; Nazirogˇlu,
2011). Hence, the TRPA1, TRPM2, TRPV1, and TRPV4 play an
important role in the nociception mediated by sensory neurons,
including the DRG (Materazzi et al., 2012; Özdemir et al.,
2016; Kahya et al., 2017). Therefore, increased ROS/RNS levels
induced by several clinical conditions may play a deleterious
effect on different biomolecules (e.g., lipids, proteins and nucleic
acids), organelles and antioxidant defenses, leading to exacerbate
nitro-oxidative stress, mitochondrial dysfunction, glial activation
and inflammatory response. Recent evidence also points out the
possible implication of TRP channels in NP. Altogether, this
adverse context is ultimately responsible of the typical painful
symptoms of NP (Figure 1).
This review summarizes current knowledge about NP,
focusing on clinical conditions and probable causes, the
relationship existing among oxidative stress, mitochondrial
dysfunction and TRP channels activation and scientific evidence
related to antioxidant supplementation.
Spinal Cord Injury
Following spinal cord injury (SCI), individuals suffer not only
motor dysfunction but also the development of chronic NP.
Up to 80% of patients experience this condition within months
after injury, which dramatically impairs their quality of life;
thus, taking in account that this kind of NP is refractory to
clinical treatments, depression and suicide are very frequently
(Stillman et al., 2017). It is thought that after SCI, many
neuroadaptation responses are implemented in dorsal horn,
triggering central mechanisms which likely contribute to NP.
Apart from dysfunction of neurons, other pathogenic events have
been defined about post-SCI pain, including pro-inflammatory
signaling, microglia activation and intracellular Ca2+ alteration;
however, little is known about how oxidative stress may play a
critical role in this condition (Hulsebosch et al., 2009; Due et al.,
2014).
Evidence supports that after a central nervous system
injury, increased extracellular glutamate levels activate several
intracellular pathways including ROS formation; this change in
redox status promotes a leukocyte mediated pro-inflammatory
response that ultimately leads to the exacerbation of secondary
damage (Hulsebosch et al., 2009). In this sense, some studies have
implicated the lipid peroxidation byproduct (acrolein) in many
neuropathological diseases and NP modalities (Shi et al., 2011).
During inflammation and trauma acrolein is released, causing
damage to biomolecules and altering several cellular processes
in neurons, including mitochondria functionality. Consequently,
this aldehyde is well known to be a potent oxidant, perpetuating
a vicious cycle of oxidative stress which may partially explain its
role as TRPA1 agonist. Due et al. (2014) have reported increased
levels of acrolein within or near the injured site for at least 2 weeks
following experimental SCI, a phenomenon which was correlated
with the onset of sensory and behavioral hypersensitivity in
rats. Moreover, exogenous administration of acrolein into rodent
spinal cord also induced pain symptomatology, whereas the
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FIGURE 1 | Summary of harmful effects of nitro-oxidative stress on neuronal cells in neuropathic pain (CAT, catalase; GPx, glutathione peroxidase; GSH, glutathione;
IL-1/6, interleukin 1/6; ROS/RNS, reactive oxygen species/reactive nitrogen species; SOD, superoxide dismutase; TNF-α, tumor necrosis factor-α; TRP, transient
receptor potential; TRPA1, transient receptor potential ankyrin 1; TRPM2, transient receptor potential melastatin 2; TRPV1/4, transient receptor potential vanilloid 1/4).
treatment with its scavenger hydralazine modestly diminished
sensitivity to both tactile and thermal stimuli. Researchers also
performed in vitro assays observing that acrolein increases
neuronal excitation. Together, these findings strongly support
the pro-nociceptive role of acrolein likely via TRPA1 activation,
as deduced by increased levels of this receptor in sensory
ganglia also observed in the referred study. But as authors
mentioned, other TRP channels might also be sensitive to
acrolein and contribute to SCI-induced NP. In accordance with
these observations, Park et al. (2014) have also reported in vivo
evidence about the crucial role of acrolein in the pathogenesis
of spinal cord trauma and the potential use of hydralazine
as analgesic. In this study, a significant reduction of acrolein
levels, tissue damage, motor deficits and NP was observed in
hydralazine-treated rats.
On the other hand, other mediators may also be part of the
pathophysiological mechanisms triggered by oxidative stress in
this kind of NP, such as aquaporin-1. Apart from mediating
several physiological processes via water transport, aquaporin-1
must also play a not still well understood role in the etiology
of different neuropathological conditions; it is supposed to
contribute to some of the typical outcomes such as edema and
cyst formation. In experimental models of SCI, this protein has
been found to be significantly elevated for up to 11 months
in sensory axons, neurons, astrocytes, and ependymal cells,
despite consequent loss of nerve tissue at the site of injury.
Experimental data point oxidative stress as one of the factors that
contributes to aquaporin-1 up-regulation since administration
of the antioxidant melatonin not only reduced protein levels
but also mechanical allodynia and appearance of aquaporin-1-
positive fibers below laminae I and II (Nesic et al., 2008).
More recently, in vivo proteomic approaches of SCI have
demonstrated that peripheral nerve injury alters the expression
and/or subcellular distribution of some specific dorsal horn
proteins, for example those involved in nociceptive signaling,
cellular metabolism, plasma membrane receptor trafficking,
oxidative stress, apoptosis and degeneration (Lee et al., 2003;
Kunz et al., 2005; Singh et al., 2009). In this sense, the TRP
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superfamily’s member TRPM4 should be mentioned. TRPM4
is a non-selective, Ca2+-impermeable channel that exclusively
transports monovalent cations. TRPM4 is activated by increased
intracellular ATP concentration and oxidative stress, but it is
inhibited by intracellular ATP depletion (Nilius et al., 2004;
Simon et al., 2010). Involvement of the Cys1093 residue oxidation
in TRPM4 channel activation has also a significant role in
oxidative stress dependent (without ATP depletion) activation
and desensitization of TRPM4. Involvement of hydrogen
peroxide (H2O2) is well known for induction of necrosis; in
endogenously expressed TRPM4 HeLa cells, H2O2 induction of
both necrosis and apoptosis has been shown (Simon et al., 2010).
TRPM4 has an important role for induction of neurological
diseases. For example, involvement of TRPM4 in etiology of SCI
was reported by result of recent papers (Gerzanich et al., 2009;
Lee et al., 2014).
Chemotherapy-Induced Peripheral
Neuropathy
Many first-line chemotherapy agents used in the current
clinical practice, such as platinum-based anticancer drugs
(i.e., cisplatin, oxaliplatin), proteasome/angiogenesis inhibitors
(bortezomib/thalidomide), vinca alkaloids (i.e., vincristine,
vinorelbine) and taxanes (i.e., paclitaxel, docetaxel) cause a
dose-limiting side effect called chemotherapy-induced peripheral
neuropathy (CIPN) (Han and Smith, 2013; Kerckhove et al.,
2017). This kind of NP involves predominantly sensory nerves
and occurs in a stocking-and-glove distribution. Depending on
anticancer drugs, 38–100% of cancer patients are affected by
CIPN and its symptoms (mainly allodynia and hypersensitivity)
may persist from months to years following cessation of
anticancer treatment, a phenomenon known as coasting. It seems
that chemotherapy regimens (drug or combination of drugs
administered and dosing), methods of pain assessment and
the individual patient characteristics (presence of comorbidities
associated with increased risk of neuropathy, such as diabetes,
depression, insomnia or genetic particularities) are some of the
several factors that may influence on the onset of CIPN and
the severity of symptoms. In addition, most of the effective
analgesics in NP failed to provide symptomatic relief of CIPN
and often exhibit side effects (Han and Smith, 2013; Griffiths and
Flatters, 2015). Thus, CIPN may limit the dosing, duration and
effectiveness of the treatment, affecting survival and quality of life
of the patient (Ji et al., 2013; Kerckhove et al., 2017).
In general, unlike other types of NP (including those induced
by trauma and diabetes) axonal degeneration in peripheral nerves
is not present in CIPN (Ji et al., 2013). For this reason, NP
is suspected to be a complex phenomenon resulting from the
interrelation of various mechanisms. It has been observed that
anticancer drugs may cause neuronal damage in a variety of
ways, such as nuclear and mitochondrial DNA damage, ion
channel disturbances (i.e., calcium, sodium and potassium),
impairment of axonal transport and inflammatory process (Han
and Smith, 2013; Massicot et al., 2013; Kerckhove et al.,
2017). More recently, experimental evidence points oxidative
stress and mitochondrial dysfunction as one of the common
pathophysiological mechanisms responsible of neurotoxicity in
CIPN. Thus, overproduction of ROS and RNS may affect
redox status toward oxidation, interfering with the antioxidant
defense system and cell function. An increase in several markers
of oxidative stress (lipid peroxidation, carbonylated proteins
and DNA oxidation) in experimental models of CIPN has
been observed; moreover, homozygous individuals for GSTP1
105Ile allele, that encode the oxidative stress regulatory enzyme
glutathione S-transferase pi 1, tend to suffer this type of NP
more frequently than other people (Han and Smith, 2013). At
mitochondrial level, structural integrity and energy function
of this organelle are affected, triggering the apoptosis cascade.
Furthermore, inefficient autophagy/mitophagy of damaged
biomolecules and organelles leads to a vicious cycle in the cells,
which ultimately exacerbates the progression of the CIPN typical
neurodegeneration. Consequently, inflammatory response is
activated in both neurons and immune system cells (Massicot
et al., 2013; Areti et al., 2014). Specific oxidative damage features
in CIPN induced by most commonly used chemotherapeutic
agents are detailed below.
Regarding to CIPN induced by the taxanes, Duggett et al.
(2016) analyzed oxidative stress in DRG neurons of rats treated
with paclitaxel at three time-points (prior to pain onset (day
7), during (peak pain) and at resolution of pain). Whereas
researchers did not find any change in mitochondrial ROS or
O•−2 levels while studying entire neuronal populations, analysis
of separately subpopulations of nociceptive neurons showed a
statistically significant increase of ROS levels in isolectin B4-
positive neurons from treated rats compared to control rats
at the three time-points studied. For authors, these results
indicate that neuronal antioxidant defenses seem to be initially
overwhelmed, leading to ROS overproduction prior to pain
onset; this phenomenon causes mitochondrial dysfunction with
increased superoxide radical levels at peak pain, triggering
signaling cascades that may underlie the coasting effect, such
as apoptosis. It has been observed that the apoptotic process in
paclitaxel induced-painful neuropathy is due to the permeability
transition pore opening, with the consequent cytochrome c
release and Ca2+ homeostasis dysregulation (Areti et al., 2014).
In this sense, Griffiths et al. (Griffiths and Flatters, 2015)
reported that the selective pharmacological modulation of the
mitochondrial electron transport chain (ETC) (at level of
complex I or III) in vivo could also reverse or attenuate the above-
mentioned symptoms, but with deleterious effects on motor
coordination in the case of complex I inhibition at 3 and 24 h after
paclitaxel administration; however, only complex III inhibition
before and during the chemotherapy exposure caused an effective
relief of pain in prophylactic studies. According to authors,
paclitaxel administration causes mitochondrial dysfunction as
first oxidative event, resulting in excessive ROS levels which could
not be counteracted by the weak antioxidant defenses of neurons;
due to this fact, ROS-driven pain behaviors start. In addition,
other studies have also demonstrated the involvement of TRP
channels in paclitaxel-induced pain, which are well known to be
predominantly expressed on this subpopulation of DRG neurons.
In fact, a specific cellular signaling pathway has been described
in mice, including the activation of protease-activated receptor 2
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and downstream enzymes phospholipase C and protein kinases A
and C by mast cell triptase, and resultant sensitization of TRPV1,
TRPV4, and TRPA1 (Chen et al., 2011). Later, Materazzi et al.
(2012) observed in vitro that paclitaxel administration induced
oxidative stress byproducts which ultimately activate TRPA1
and TRPV4. Thus, pharmacological TRP channel targeting
may offer a future possibility to attenuate paclitaxel-induced
mechanical and thermal hypersensitivity in clinical practice. In
summary, as Kerckhove et al. (2017) point the oxidative stress
in taxanes induced-NP not only causes damage to neuronal and
non-neuronal cells, but also macrophage activation, with the
consequent overproduction of pro-inflammatory cytokines, such
as TNF-α and IL-1β. In fact, Li et al. (2015) have recently reported
that paclitaxel treatment may also trigger pro-inflammatory
mechanisms inDRGneurons via toll-like receptor 4, which is also
associated to the sensitization of TRPV1.
On the other hand, platinum compounds such as oxaliplatin
have a strong neurotoxicity compared to other anticancer drugs;
more than 90% of patients develop acute neuropathy which
could become chronic in a 30–50% of the cases. However,
the complex machinery underlying CIPN is poorly understood.
To date, it has been observed that the treatment with this
kind of antitumor agents causes ROS generation, mitochondrial
dysfunction (including frataxin deficiency, mitochondrial DNA
damage and defective components of ETC), loss in antioxidant
enzymes, ion channels disturbances and nerve tissue damage
(protein carbonylation and lipid peroxidation) (Areti et al., 2014;
Kerckhove et al., 2017). It is thought that various receptors
and molecular pathways must be involved in the sensitization
of peripheral and central sensory nerves, and thus, in the
chronicity of CIPN. Recently, Massicot et al. (2013) have
described in vitro and in vivo biochemical effects after exposure to
high concentrations of oxaliplatin, including neuronal activation
of the purinoreceptor subtype 7, ROS and •NO production, lipid
peroxidation, loss of mitochondrial transmembrane potential
and further apoptosis via caspase 3 activation. Regarding to
immune response, oxaliplatin-treated neurons release significant
amounts of pro-inflammatory cytokines, mainly TNF-α and IL-
6, whereas prostaglandin E2 levels were significantly higher
in macrophagues exposed to the platinum compound than in
control cells. These inflammatory mediators might stimulate
nociceptors, leading to generation and further chronification of
painful symptoms. Overall, authors suggest that oxidative stress
along with purinoreceptor subtype 7/inflammasome pathway
would play a persistent role in oxaliplatin-induced neurotoxicity
and its transition from acute to chronic NP. In addition,
purinoreceptor subtype 7 activation has been observed to
cause caspase-1 activation, which is ultimately involved in the
expression of cyclooxygenase 2 and prostaglandin E2 and IL-β
production.
Recently, vinca alkaloids have demonstrated to exert their
neurotoxicity via activation of spinal cord glia (i.e., astrocytes
and microglia), offering an option for the treatment of CIPN
through pharmacological antagonism of this phenomenon. For
authors such as Ji et al. (2013) spinal astrocytic activation, but
no microglial activation, seems to contribute to mechanical
allodynia in vincristine-treated rats, leading to overexpression
of IL-β. This pro-inflammatory mediator might bind to
its endogenous receptor to induce N-methyl-D-aspartic acid
receptor phosphorylation in spinal dorsal horn neurons; thus,
neuronal activity and nociceptive signaling would be enhanced.
On the contrary, other studies have reported both astrocytic
and microglial activation (Sweitzer et al., 2006; Kiguchi et al.,
2008) after vincristine exposure, as well as up-regulation of other
inflammatory cytokines such as TNF-α (Kiguchi et al., 2008).
As mentioned by Ji et al. (2013), methodological differences
(i.e., animal model, dosage and route of administration, etc.)
might be one of the reasons for this discrepancy. In any case,
oxidative stress would trigger the glial activation, as well as
other processes. A study performed in vivo has revealed that
vincristine-induced ROS overproduction may also increase the
activity of the enzyme dipeptidylpeptidase IV and decrease the
levels of spinal endomorphin-2. Authors’ hypothesis reveals
that the loss of this kind of endogenous inhibitory signal
might contribute to allodynia and central sensitization, with the
subsequent development of chronic pain.
Finally, bortemozib and thalidomide are well known to act
as proteasome/angiogenesis inhibitors. However, a proteasome-
independent mechanism might also contribute to CIPN; thus,
mitochondrial dysfunction may also be involved (Kerckhove
et al., 2017). Recently, Zheng et al. (2012) have reported in rat
sciatic nerve how bortemozib, as other antitumor drugs, causes
significant deficits in complex I and II of ETC, as well as in ATP
production, at two time points (pain onset -day 7- and peak pain
-day 35-).
Therefore, scientific evidence highlights the importance of
early oxidative stress in the CIPN onset. But the important
question that remains unresolved is: what happens first after
chemotherapy administration? Mitochondrial dysfunction or
increased ROS levels? In any case, this context leads to a
vicious cycle which compromises ATP production and neuronal
viability (Figure 2). Experts agree that, experimentally, the period
between the last injection of the antitumoral agent and the time
of normal onset of pain is a crucial window for an effective
ROS scavenging. Taking into account all the above-mentioned,
monitoring oxidative stress related-parameters during the course
of CIPN could be helpful in clinical practice (Areti et al., 2014).
Moreover, some studies have demonstrated the effectiveness of
antioxidant therapies in this kind of neuropathic pain. These
promising results about antioxidant supplementation in CIPN
will be discussed later.
Diabetic Neuropathy
Peripheral diabetic neuropathy (PDN) is the most common
diabetic complication in patients with diabetes (both type 1 and
type 2). It may appear as a painful and insensate neuropathy,
compromising patient’s functionality, mood and quality of life.
Symptomatology (i.e., paresthesia, spontaneous pain, tactile
allodynia and mechanical and thermal hypo/hyperalgesia) may
improve and resolve spontaneously, or culminate in total loss
of sensation and ultimately in foot ulceration and amputation.
Current clinical strategies for the management of PDN include
glycolic control and treatment with drugs such as tricyclic
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FIGURE 2 | Relation between nitro-oxidative stress, mitochondrial dysfunction
and apoptosis in chemotherapy-induced peripheral neuropathy (ATP,
adenosine triphosphate; ETC, electronic transport channel; mtDNA,
mitochondrial DNA; mPTP, mitochondrial permeability transition pore;
ROS/RNS, reactive oxygen species/reactive nitrogen species).
compounds, serotonin noradrenalin reuptake inhibitors, α-
lipoic acid, anticonvulsants, opiates, membrane stabilizers and
topical capsaicin; however, these therapeutic options are often
inefficient, have significant side effects and its prescription
depends on the presence of comorbidities (Obrosova et al., 2008;
Pacher, 2008; Obrosova, 2009; Tesfaye, 2011; Ma et al., 2015).
Pathogenesis of PDN is poorly understood, but it is quite
clear that hyperglycemia plays a vital role in the development
of this diabetic complication. Experimental evidence points a
multifactorial etiology, linking hyperglycemia with the activation
of multiple cell phenomena such as polyol pathway, advanced
glycation end-products formation, protein kinase C (PKC)
and nuclear factor Kβ signaling, among many others (Pacher,
2008; Obrosova, 2009). It should be noted that, among
other physiological effects, chronic hyperglycemia leads to an
imbalance of the oxidative status, affecting central and peripheral
nervous system; hence, nitro-oxidative stress is also thought
to be one of the responsible factors of nervous degeneration
that characterize PDN (Mirshekar et al., 2010; Tesfaye, 2011).
In diabetic state, hyperglycemia leads to overproduction of free
radicals (i.e., mitochondrial O•−2 ,
•NO and peroxynitrite) mainly
derived from glucose oxidation and lipid peroxidation, which
cause oxidative damage to biomolecules. In particular, it is well
known that oxidative DNA damage triggers the over-activation
of the nuclear enzyme poly (ADP-ribose) polymerase-1 (PARP-
1). An in vivo study performed byObrosova (2009) demonstrated
that administration of a PARP inhibitor counteract small sensory
nerve fiber dysfunction and degeneration. Therefore, PARP-1
activation seems to play an important role in the pathogenesis of
PDN in several ways, likely including the regulation of various
important inflammatory pathways. In this sense, other studies
have observed increased levels of TNF-α in diabetic animal
tissues (Satoh et al., 2003; Skundric and Lisak, 2003). In addition,
Ma et al. (2015) reported the role of mitochondrial bioenergetics
deficits in PDN and its possible link with immune response.
As authors highlighted, inflammatory signaling may lead to
inhibition of ETC activity, through induction of changes in
the phosphorylation state of proteins and the reduction of the
mitochondrial membrane potential. Taking evidence in account,
more studies are necessary to go deep into the participation of
oxidative stress, mitochondrial dysfunction and inflammatory
response in the development of PDN.
Alcoholic Peripheral Neuropathy
Long-term excessive consumption of alcohol may lead to a
condition known as alcoholic peripheral neuropathy (APN).
Like other types of NP, it is characterized by spontaneous
pain, hyperalgesia and allodynia. Regarding to APN related-
risk factors, duration and amount of total lifetime alcohol
consumption have been demonstrated as the most determinants;
interestingly, a higher prevalence has been found in women than
men (Chopra and Tiwari, 2012). Although little is known about
physiopathological mechanisms underlying APN, a combination
of direct toxic effects of ethanol or its metabolites and nutritional
deficiencies (mainly thiamine) may offer a plausible explanation
to this complication.
To date, different molecular mechanisms (i.e., PKC and
nuclear factor Kβ) (Dina et al., 2000), signaling pathways (i.e.,
MEK/ERK and apoptosis via caspase activation) (Jung et al.,
2005; Dina et al., 2007), receptors (i.e., metabotropic glutamate
and µ opioid receptors) (Miyoshi et al., 2007; Narita et al.,
2007), nerve cells (i.e., astrocytes and microglia) (Narita et al.,
2007) and neuroendocrine stress axis (i.e., sympatho-adrenal
and hypothalamo-pituitary-adrenal axis) (Dina et al., 2008) have
shown to be involved in the APN. Focusing oxidative stress,
some studies have indicated that in heavy drinkers increased
nitro-oxidative stress plays a pivotal role in the neuronal
damage. This imbalance in redox status might be caused by
acetaldehyde, a highly toxic and reactive metabolite derived
from the biphasic catabolic conversion of ethanol to acetate,
in particular, as a byproduct of the mitochondrial enzyme
acetaldehyde dehydrogenase. In the liver, acetaldehyde is known
to cause impairment of mitochondrial ETC and stimulation of
inflammatory response, among other toxic effects (Chopra and
Tiwari, 2012). Therefore, mitochondrial dysfunction may also
lead to an inefficient detoxification and subsequent accumulation
of acetaldehyde, worsening redox status and cytotoxic effects
on biomolecules, including proteins, lipids and DNA. In this
context, some in vivo studies have demonstrated that several
oxidative markers are affected by following ethanol chronic
administration. For example, glutathione (GSH) levels and GSH
peroxidase activity have been observed to be diminished in
the sciatic nerves of ethanol-fed rats compared to pair-fed
rats; on the contrary, the amount of the lipid peroxidation
product malondialdehyde increased in the same tissue (Bosch-
Morell et al., 1998). More recently, Tiwari et al. (Tiwari et al.,
2009, 2011) have confirmed significant increased levels of lipid
peroxidation andmarked decrease in GSH, superoxide dismutase
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and catalase activities in the sciatic nerve of rats which were
given alcohol for 10 weeks. Alcohol has been also found to
enhanced production of hydrogen peroxide and •OH like species
(Dicker and Cederbaum, 1992). As mentioned above, ROS
overproduction may lead to sensitization of dorsal horn cells,
activation of spinal glial cells and inflammatory response, which
ultimately activate PKC and nuclear factor Kβ translocation,
MEK/ERK signaling and apoptosis.
Oxidative Stress Dependent TRP Channels
and Pain
It is well known that ROS and RNS are produced in several
physiological functions, such as mitochondrial and cytochromes
P450 activities. These free radicals are scavenged by enzymatic
and non-enzymatic antioxidants. At 2002, two different groups
from Kyoto-Japan (Bautista et al., 2005) and Aachen-Germany
(Kistner et al., 2016) reported activation of a TRP channel namely
LTRPC2 (former name of TRPM2) by RNS and ROS. Today,
9 TRP channels (TRPA1, TRPC5, TRPM2, TRPM4, TRPM7,
TRPV1, TRPV2, TRPV3, and TRPV4) are demonstrated to be
activated by oxidative stress (Mori et al., 2016). Expression levels
of these channels are very different in tissues and cells. For
example, it has been observed that the expression levels of four
TRP channels (TRPA1, TRPM2, TRPV1 and TRPV4) are high in
neurons related to nociception. Hence, this section is focused on
these four TRP channels.
TRPA1
Cysteine is a sulfur-containing amino acid in humans. Cysteine,
as a source of thiol redox system, acts also as the main source
of different antioxidants such as GSH, glutathione peroxidase,
N acetyl cysteine (NAC) and α-lipoic acid. Hence, the cysteine
groups are main target for ROS and RNS (Sen and Packer, 2000;
Nazirogˇlu, 2007).
The TRPA1 channels are activated by different stimuli
including chemicals (mustard oil and cinnamaldehyde) and
cold body temperature (≤17◦C). In addition, TRPA1 is also
an oxidative stress-sensitive Ca2+-permeable channel. Therefore,
activation of TRPA1 in neurons by oxidative stress such as H2O2
was reported (Materazzi et al., 2012; Bai and Lipski, 2013; Toda
et al., 2016). Furthermore, the TRPA1 channel is activated by
depletion of intracellular GSH, although its activation in the DRG
neurons was inhibited by antioxidants of thiol redox system, such
as GSH and selenium (Materazzi et al., 2012; Özdemir et al., 2016;
Kahya et al., 2017) (Table 1).
It is well known that increase of intracellular ROS, RNS and
Ca2+ has main roles in etiology of pain processes (Kallenborn-
Gerhardt et al., 2012; Ogawa et al., 2016). As it was mentioned
above, the TRPA1 and TRPV4 channels are activated by
different stimuli, including oxidative stress (Bai and Lipski, 2013).
Involvement of TRPA1 channels in the etiology of pain processes
has not been fully clarified yet, although there are some reports
on TRPA1 activation-induced pain processes such as diabetic
peripheral pain (Andersson et al., 2015; Jardín et al., 2017; Kahya
et al., 2017) and SCI-induced pain (Park et al., 2015; Klafke et al.,
2016) and chemotherapeutic agent-induced pain (Naziroglu and
Braidy, 2017) through excessive ROS and RNS production in the
rodents. In addition, it was reported in DRG neurons of wild
typemice and TRPA1 knockoutmice that activation of TRPV1 by
chemotherapeutic agents induced excessive ROS production and
mechanical allodynia. However, TRPA1 and TRPV4 antagonist
treatments induced decrease on the allodynia and oxidative stress
in the mice (Materazzi et al., 2012). In a previous study, the same
group did not observe Ca2+ response effects induced by exposure
to chemotherapeutic agents in cultured mouse DRG and Chinese
hamster ovary (CHO) cell line (Nassini et al., 2011), although
chemotherapeutic agent evoked an antioxidant GSH-sensitive
Ca2+ response in the CHO cell line and DRG neuron. Results of a
study indicated that chemotherapeutic agents-induced oxidative
stress caused TRPA1 activation instead of direct channel targeting
(Nassini et al., 2011). The report was confirmed by a recent
study; thus, it was observed that chemotherapeutic agent-induced
increase of TRPA1 expression, cell death and neuropathic pain in
mice DRG was reduced by aluminum and GSH treatment (Lee
et al., 2017). TRPA1 activator role of hydrogen sulfide through
nitric oxide production was recently reported in DRG neuron too
(Miyamoto et al., 2017), as shown in Table 1.
There is a synergic interaction between TRPA1 and TRPV1
on channel activation mechanisms in DRG, because TRPA1 is
co-localized with 30–50% TRPV1 expressing neurons in rat and
human DRG (Bautista et al., 2005). Therefore, the sensitization
ratio of TRPA1 is affected by several factors, including oxidative
stress and TRPV1 blocker (Kistner et al., 2016; Ogawa et al.,
2016). On the subject, increased sensitization of human TRPA1 in
DRG neuron was reported by inflammation and oxidative stress,
although the increased sensitization in the neuron is decreased by
antioxidant NAC and capsazepine (Kistner et al., 2016).
TRPM2
Another member of TRP superfamily is TRPM2. The enzyme
(ADP ribose) pyrophosphatase in the C-terminal domain of
TRPM2 contains is sensitive to ROS and RNS (Nazirogˇlu, 2007).
TRPM2 channel in transfected cell lines is gated by extracellular
and intracellular ROS, possibly by interacting with the ADP
ribose pyrophosphatase enzyme in the tail of the protein C
domain (Perraud et al., 2001; Hara et al., 2002; Wehage et al.,
2002). Later, TRPM2 activator role of oxidative stress from
ADPR was reported in transfected cells by single channel patch-
clamp experiments (Naziroglu and Lückhoff, 2008). Presence of
TRPM2 function in DRG neuron was firstly reported in 2011
(Nazirogˇlu et al., 2011a). It was highlighted that the excessive ROS
production through activation of NADPH oxidase contributes
to sensitization in DRG neuron for persistent pain induction
(Kallenborn-Gerhardt et al., 2012). Result of a more recent
study indicated involvement of NADPH oxidase on TRPM2
channel activation in DRG neuron (Nazirogˇlu, 2017) (Table 1).
In addition to the TRPA1 channel, involvement of cysteine
groups on the activation of TRPM2 channels in transfected
human embryonic kidney (HEK-293) cells was reported (Mei
et al., 2006). Then, protective roles of GSH and NAC as members
of thiol redox system on TRPM2 channel and peripheral pain
inhibition in DRG neuron were also reported (Nazirogˇlu et al.,
2011b; Özgül and Nazirogˇlu, 2012; Sözbir and Nazirogˇlu, 2017)
(Table 1). It seems that members of thiol redox system have
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TABLE 1 | Role of reactive oxygen species (ROS) and reactive nitrogen species (RNS) on the activation of transient receptor potential channels (TRPA1, TRPM2, TRPV1,
and TRPV4) in the peripheral neuron.
Channel ROS/RNS Material Value Reference
TRPA1 H2O2, Rat DRG Protective role of GSH on peripheral pain
through inhibition of cysteine oxidation.
Bosch-Morell et al., 1998; Materazzi
et al., 2012
TRPA1 Nitric oxide Rat DRG Protective role of dithiothreitol, cysteine and
GSH on peripheral pain through inhibition of
nitric oxide production.
Nazirogˇlu, 2007; Tiwari et al., 2011
TRPM2 ADP-ribose and H2O2 Rat DRG NADPH oxidase dependent activation of
TRPM2
Naziroglu and Braidy, 2017
TRPM2 ADP-ribose and H2O2 Rat DRG Protective role of GSH and NAC on
peripheral pain and channel activation
through inhibition of oxide stress.
Lee et al., 2017; Miyamoto et al.,
2017; Naziroglu and Braidy, 2017
TRPV1 H2O2 and nerve growth factor Rat DRG Protective role of GSH, selenium and NAC on
hyperalgesia and channel activation through
inhibition of oxide stress.
Mei et al., 2006; Nazirogˇlu et al.,
2011b; Kahya et al., 2017
TRPV1 H2O2 Mice DRG Oxidative stress-induced inflammatory
hyperalgesia
Sözbir and Nazirogˇlu, 2017
TRPV1 RNS and NADPH oxidase Mice and Rat DRG Oxidative stress-induced inflammatory
hyperalgesia and channel activation
Caterina et al., 1997; Naziroglu and
Braidy, 2017
TRPV4 H2O2 and ROS Rat DRG Protective role of GSH on peripheral pain
through inhibition of cysteine oxidation
Dina et al., 2008; Materazzi et al.,
2012
TRPV4 ROS Rat DRG Protective role of TRPV4 blockers on
mechanical allodynia and oxidative stress
Materazzi et al., 2012
important roles on inhibition of oxidative stress-dependent
TPM2 channel activation and peripheral pain in rodents.
TRPV1
A subfamily of TRP superfamily is vanilloid family. TRPV1
is a member of the vanilloid subfamily. The channel was
firstly expressed in rats through activation of high temperature
and pungent hot chili pepper component (capsaicin) in mice
DRG neuron (Caterina et al., 1997). The channel can also
be activated by different stimuli including low pH (<5.9),
high temperature (>43◦C) and oxidative stress leading to
the perception of pain, and oxidative injury (Yoshida et al.,
2006). As most of cation channel protein, TRPV1 channel
protein contains six transmembrane domains. Similar to TRPA1
(Takahashi et al., 2011) and TRPM2 (Mei et al., 2006)
membrane structure, oxidative alterations of multiple Cys
residues in different cells are involved in this mode of TRPV1
activation by modifying (Yoshida et al., 2006; Chuang and
Lin, 2009) and disulfide bond formation (Wang and Chuang,
2011). Therefore, the TRPV1 is activated in rat DRG neuron
by depletion of intracellular GSH (Naziroglu et al., 2013),
although hyperalgesia and the TRPV1 channel were inhibited
in the DRG neurons of rats by treatment of thiol redox
cycle members such as GSH, selenium and NAC (Khodorova
et al., 2013; Naziroglu et al., 2013; Kahya et al., 2017)
(Table 1).
Excessive ROS are produced in physiological functions such
as mitochondrial function and phagocytic activity. During the
killing bacteria and virus, ROS are used in the anti-inflammatory
cells such as macrophages microphages andmicroglia. Therefore,
there is a direct relationship between increased levels of ROS
and inflammatory hyperalgesia (Oehler et al., 2017). Interactions
between TRPV1 and long sustained thermal hypersensitivity in
oxidative stress-induced inflammatory hyperalgesia of mouse
hind paw were reported (Keeble et al., 2009). Therefore, there is
a direct role of oxidative stress through activation of TRPV1 on
hyperalgesia in DRGneuron of wild type andNox1 deficientmice
(Ibi et al., 2008) (Table 1). Niflumic acid is also a TRPV1 channel
antagonist and it was reported that peripheral neuropathy
by suppressing excessive ROS, RNS, inflammatory cytokine
production and TRPV1 activation in neuropathic pain-induced
rats were recovered by the niflumic acid treatment (Marwaha
et al., 2016).
TRPV4
A member of TRP superfamily is TRPV4 and it was firstly
described with mammalian osmo-transducer property (Liedtke
et al., 2000). The channel is also activated by phorbol
esters, low pH, citrate, arachidonic acid, exogenous chemicals
(bisandrographolide A) and heat (24◦C ≥) (Güler et al.,
2002; Yoshida et al., 2006). In addition to the stimulators,
activation of TRPV4 in neurons by oxidative stress such as
H2O2 was reported (Materazzi et al., 2012; Bai and Lipski,
2013), although its activation in the DRG neurons was
inhibited by GSH (Materazzi et al., 2012) (Table 1). It was
also reported in DRG neurons of wild type and TRPV4
knockout mice that activation of TRPV4 by paclitaxel induced
mechanical allodynia and excessive ROS production, although
the allodynia and oxidative stress was partially decreased
by the TRPV4 antagonist treatment (Materazzi et al., 2012)
(Table 1).
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Role of Other Factors on TRP Channels
and Pain
In addition to the oxidative stress, several other factors play
a role in the induction of CIPN with/without TRP channel
activation, including glutamate receptors, neuropeptides, PKC
and inflammation. Although their role in CIPN has been known
for a long time, there are limited reports about the interaction
between these factors and TRP channels in the literature. In
this section, some brief information is given about other main
factors and TRP channels activation related to pain induction in
experimental animals.
1) Glutamate receptors and neuropeptides: Many types of
ionotropic glutamate receptors were reported in literature.
Presence of three types of ligand-gated glutamate ion channel
receptors such as N-methyl-D-aspartate, α-amino-3-hydroxy-
5-methyl-4-isoxazolepropionic acid, and kainite receptors has
been known for a long time. Their involvement in CIPN
was also investigated by numerous papers (Wu and Zhuo,
2009; Vécsei et al., 2015). On the other hand, substance
P and calcitonin-gene-related-neuropeptide are well known
neuropeptides in the induction of peripheral neuropathy and
nociception. Their implication in CIPN through the overload
of Ca2+ entry has been demonstrated (Hill and Oliver,
2007; Nassini et al., 2014). In addition, recent studies have
pointed out the involvement of neuropeptides on TRP channel
activation, such as TRPA1, TRPM8 and TRPV1 (Nassini et al.,
2014; Chukyo et al., 2018). For example, it was observed that
substance P was potentiated by the sensitization of TRPV1
(Marwaha et al., 2016).
2) PKC enzyme: Apart from the involvement of PKC on the
induction of oxidative stress in neurons, both human and
animal studies have linked this enzyme to several pain types
through excessive Ca2+ entry and cation channel activation
(Carozzi et al., 2015; Kumar et al., 2017). In this sense,
the involvement of PKC in experimental models of CIPN
was also evidenced by several papers, although mechanical
hyperalgesia was decreased by the treatment with PKC
inhibitors such as hypericin and calphostin C (Norcini et al.,
2009). Sensitivities of nociceptive neurons to heat stimulation
and TRPV1 activation were increased by the activation of
PKC and inflammatory mediators (Khasar et al., 1999; Gao
et al., 2016). There is also direct relationship between PKC
and onset of mechanical hyperalgesia (Khasar et al., 1999;
Hucho et al., 2006). It was reported that paclitaxel-induced
mechanical hypersensitivity were increased in the DRG of
mice by up-regulation of PKC (Dutra et al., 2015). Moreover,
antioxidants such as quercetin were able to inhibit TRPV1 and
PKC activations in a study of paclitaxel-induced peripheral
neuropathy (Gao et al., 2016).
3) Inflammation: Brain and spinal glia neurons have a main
role on homeostasis in central nervous system and peripheral
nervous system. The glial cells have been shown to contribute
to the development of chronic pain as results of surgery,
inflammation, and SCI. Therefore, reduction of NP was
observed by treatment of the glial activity (Carozzi et al.,
2015). Involvement of oxidative stress-induced inflammation
was reflected in other parts of this review (see “Chemotherapy-
induced peripheral neuropathy” and “Spinal cord injury”
sections). The increased glial neuron-induced inflammation
induces pain through TRP channel activation in DRG and
spinal cord neurons. For example, TRPV1 and TRPA1 are
activated by several stimuli related with traumatic brain
injury, including mechanical shear stress, leading to the
release of substance P and inflammation (Corrigan et al.,
2016). Enhanced expression and spinal inflammation-induced
sensitization of TRPV1 and streptozotocin-induced thermal
hyperalgesia and neuropathy were reported in rats (Bishnoi
et al., 2011). Involvement of TRPV1 in the activation of spinal
glia in mice with nociceptive, inflammatory and neuropathic
pain was also reported (Chen et al., 2009).
Antioxidant Supplementation
In general, scientific evidence reinforces the future use of
antioxidant supplementation in several pathological conditions.
Taking in account previous works of our research group
(Carrasco et al., 2013, 2014a,b) and other authors, both
preventive and therapeutic uses of antioxidants have been
reported to reduce not only oxidative stress related parameters
but also inflammatory response and pain in several diseases. As
mentioned earlier, it has been demonstrated that current drugs
used in the management of different kinds of NP are ineffective
and usually not safe for the patient. For this reason, antioxidant
supplementation might be an alternative to take in account in
clinical practice.
As an illustration, oral administration of molecular hydrogen
may have therapeutic potential for the management of NP.
Unlike other antioxidants, hydrogen reaches target organs easily,
where selectively neutralizes •OH, and does not accumulate
in living cells nor produce noxious metabolites (Kawaguchi
et al., 2014). Naringenin, an abundant flavanone in citrus fruits
(Kaulaskar et al., 2012) and genistein, a natural phytoestrogen
from soybean (Valsecchi et al., 2008), have been exhibited
analgesic, antioxidant and immunoregulatory properties in
sciatic nerve injury models. α-lipoic acid treatment (600 mg/day)
has also demonstrated to improve neuropathic symptoms (pain,
burning, paresthesia, and numbness) and deficits in patients with
NP (Tesfaye, 2011).
Concerning antioxidant supplementation in CINP, natural
antioxidants such as curcumin (Al Moundhri et al., 2013),
silibinin, α-tocopherol (Kerckhove et al., 2017), rutin and
quercetin (Azevedo et al., 2013) have exhibited antinociceptive
effects in oxaliplatin induced-CINP. For example, administration
of the flavonoids rutin and quercetin has shown to diminish
oxidative phenomena including lipid peroxidation, nitrosylation
and iNOS expression, as well as pain symptomatology (thermal
and mechanical allodynia) in treated mice compared to non-
treated ones (Azevedo et al., 2013). Likewise, the thiol compound
NAChas demonstrated to exert a beneficial effect in the treatment
of oxaliplatin induced-CINP, significantly reducing inflammatory
response (TNF-α, IL-1β and IL-6) in the neuroblastoma cell
line SH-SY5Y; additionally, researchers also observed that NAC
prevented apoptosis by inhibition of P2X7 receptor activation by
blocking ROS production and caspase-3 activation. Interestingly,
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in this study NAC exhibited the highest preventive effect
compared to other drugs also tested such as ibuprofen and
acetaminophen (Massicot et al., 2013). On the other hand,
prophylactic treatment with acetyl-L-carnitine has demonstrated
to prevent paclitaxel-, oxaliplatin- and bortezomib-induced
mitochondrial dysfunction and pain (Zheng et al., 2012). In spite
of the promising results, most clinical studies related to the use of
antioxidants as chemotherapy adjuncts did not report on their
impact on anticancer efficacy; hence, as Han et al. (Han and
Smith, 2013) highlighted this is an important question which
should be examined in greater depth. In this sense, previous
in vitro studies performed by our research group have shown
that co-administration of conventional chemotherapeutic agents
with antioxidants such asmelatonin enhances chemotherapeutic-
induced cytotoxicity and apoptosis in different cancer cell lines
(Uguz et al., 2012; Pariente et al., 2016, 2017a,b). In addition,
since some studies have also recorded failure in antioxidant
supplementation efficacy, optimal design of clinical trials in
terms of targeted delivery of antioxidants, clinical pathology
and concentration dependent dosage schedule is needed to go
ahead in the knowledge and future application of this kind of
treatment in CIPN (Kamat et al., 2008). Finally, as Areti et al.
(2014) point out monitoring oxidative stress related-parameters
(i.e., levels of malondialdehyde, GSH, superoxide dismutase and
activities of mitochondrial enzymes such as citrate synthase and
ATP synthase) during the course of CIPN could be helpful in
clinical practice.
Future Consideration
Taking in account the scientific evidence summarized in this
review, NP is a complex network of several molecular processes,
including nitro-oxidative stress, immune response, and TRP
channels activation, among others. Noteworthy, NP seems to
be not only promoted by direct injury to neurons but also
by TRP channels mediating damage in the surrounding tissue.
However, the way how these actors and other factors (e.g., sodium
channels, acid-sensing ion channels and synaptic receptors) are
interconnected leading to noxious symptomatology remains to
be unresolved.
Since 1990s, with the discovery of TRP channels, our
understanding about nociception has changed. Most nociceptive
TRP channels are predominantly expressed in peripheral sensory
neurons, but there is also a significant expression in the central
nervous system and other tissue and cell types (i.e., keratinocytes,
vascular endothelial cells, bladder epithelial cells, fibroblasts and
human dental pulp) (Mickle et al., 2016). Thus, we are still far
from a complete understanding of the biology of nociception
and its applicability in clinical practice. Current evidence points
out the possibility that multiple nociceptive TRP channels are
activated during pathological conditions, including the nine
oxidative sensitive-TRP channels known until today. Although
there are several reports on four oxidative sensitive-TRP channels
reviewed in this paper, there is no report linking the remaining
oxidative sensitive-TRP channels (TRPM4, TRPM7, and TRPC5)
and pain in the peripheral neurons. In this sense, contradictory
results have been obtained about the expression of certain TRP
channels in DRG neurons, such as TRPV4; in addition, TRPV2-6
and TRPM3 expression at this level is unknown. Furthermore,
information about some important aspects related to TRP
channels, including their location, trafficking, functionality and
overlapping in neurons and other kind of cells, both in
physiological and pathophysiological states, is lacking. Besides
their neuronal/plasma membrane location, it has been observed
that a significant fraction of TRP channels is also present in
organelles membranes which may be translocated as required
by cells exposed to injury/inflammation (Mickle et al., 2016).
Finally, it should be noted that some populations consume large
amounts of capsaicin, which is well known to activate TRPV1
channels and to induce overload Ca2+ entry in hippocampal and
DRG neurons (Kahya et al., 2017). In recent papers, we have
reported the involvement of TRPV1 channels in the induction
of epilepsy (Nazirogˇlu, 2015; Naziroglu and Övey, 2015). In
this sense, some Turkish populations have been traditionally
consuming high amounts of hot chili pepper (capsaicin) in food
and it has been observed a high incidence of epilepsy in these
areas (unpublished data). Thus, similar possible relationship
between high amount hot chili pepper consumption and several
peripheral pain inductions should be investigated by future
studies. Furthermore, the relevance of TRPs in NP will remain
elusive until experimental studies (including knockdown or
knockout animal models) demonstrate that an increase in TRP
activity by exogenous TRP activators produces NP.
In any case, TRP channels are now presented as attractive
targets for the development of new-generation analgesics.
Until today, there are many small molecule blockers of
TRPV1 (AZD1386) (Clinical Trials, 2012), TRPA1 (GRC-17536)
(Clinical Trials, 2014) and TRPV3 (SAR292833) (Clinical Trials,
2016), apart from topical TRPV1 agonists, such as zucapsaicin
(Clinical Trials, 2011) and NGX 4010 (Mou et al., 2014), that
have been tested in clinical trials of several NP conditions; to
the best of our knowledge, NGX 4010 is the only compound
that has been launched for clinical use in human post-herpetic
neuralgia-NP conditions. Concerning to cancer pain, a phase
I clinical trial is being carried out to determine the efficacy of
periganglionic/intrathecal administration of the potent TRPV1
agonist resiniferatoxin in advanced cancer patients with bone
pain (Clinical Trials, 2017). However, it is suspected that other
nociceptive TRP channels may be involved in cancer pain.
Therefore, this and other questions, such as efficacy and site of
action of drugs targeting nociceptive TRP channels, will need to
be answered in the next years.
CONCLUSIONS
NP is an underestimated socioeconomic health problem affecting
millions of people worldwide, which incidence may increase in
the next years due to chronification of several diseases such as
cancer and diabetes. Nitro-oxidative stress and inflammatory
response, with the consequent activation of TRP channels, seem
to play a major role in the beginning and development of
NP. Hence, it is now urgent to discover new, effective and
safe strategies to prevent and/or treat this hardly bearable
condition. Recent discoveries in different biomedical fields
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point out the need to change paradigms about pharmacological
management of diseases. From our point of view, therapeutic
options must not only be directed to reach a molecular target,
which ultimately would represent a fixed picture of the disease,
but also to restore physiological global context in terms of
nitro-oxidative stress and inflammatory response, just as the
antioxidant treatment seems to act. Furthermore, increasing
aging population and chronic diseases prevalence demand the
development and implementation of antioxidant therapies in
clinical practice. But it must not be forgotten that possible
prevention of several diseases following a varied and balanced
diet, as well as other healthy habits, is a reality nowadays. Health
care institutions, clinicians and general populationmust be aware
of the importance of nutrition, as source of natural antioxidants,
in our physical and mental state, as much in health as in
illness.
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